The degree of formality in a risk management process should be customized to the organization’s particular needs and the risks involved.
Ghada Haddad
Advertisement
Ghada Haddad, PhD, is executive director, Global Quality Transformation Global Quality Shared Services & Regulatory Intelligence Merck & Co.
Articles by Ghada Haddad
Advertisement
Latest Updated Articles
Navigating the Formality Spectrum in ICH Q9(R1)Published: July 3rd 2023 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
CPHI 2025 Awards Spotlight Breakthroughs in Pharmaceutical Manufacturing and API Development
2
The Key Trends Driving Supply Chain Localization and Data Scrutiny in Biopharma
3
Clearing Hurdles in Sustainability, AI, and CDMO Partnerships
4
Excipient Innovation, Safer Solvents, and Supply Chain Resilience
5
